Table 1 Baseline clinical characteristics of participants included in the analysis
From: The insula represents a key neurobiological pain hub in psoriatic arthritis
Clinical features (n = 46) | |
|---|---|
Age (mean ± SD) | 49 ± 11.2 |
Disease duration (years, mean ± SD) | 6.4 ± 5.8 |
Sex (male/female) | 22/24 |
BMI (mean ± SD) | 29 ± 4.5 |
FM criteria fulfilled (%) | 43.5% |
FM total score (mean ± SD) | 12.5 ± 5.7 |
Current overall body pain NRS 0-100 (mean ± SD) | 34.8 ± 23.5 |
Number of previous DMARDs (including biologics) • 0–1 • 2–4 • > 4 | 17 17 12 |
TJC 66 (mean ± SD) | 21 ± 14 |
SJC 68 (mean ± SD) | 7 ± 4.3 |
CRP (mg/dL, mean ± SD) | 1 ± 2.5 |
Patient gVAS (mean ± SD) | 59 ± 22 |
DAPSA (mean ± SD) | 40.8 ± 19 |
LEI score (mean ± SD) | 2.7 ± 2 |
BASDAI (mean ± SD) | 6.2 ± 1.8 |